Literature DB >> 2852863

Bronchial carcinoid with S-100 positive sustentacular cells.

M Barbareschi1, S Ferrero, B Frigo, C Mariscotti, L Mosca.   

Abstract

A case of double bronchial typical carcinoid of the central type, with a nodal metastasis and paraneoplastic Cushing syndrome is reported. The case is remarkable because both the primary tumors and nodal metastasis were composed of a double cell population: one was arranged in nests, was argyrophilic, immunostained with PHE-5 monoclonal antibody, and contained neurosecretory granules; the other one was neither argyrophilic nor PHE-5-immunoreactive, but was strongly immunoreactive for S-100 protein, had a stellate morphology and was at the periphery of the nests of the other cells. The S-100 immunoreactive cells were regarded as a sort of "sustentacular" or "satellite" cells, which are themselves neoplastic. Bronchial carcinoids with S-100 positive cells, although strictly related with other bronchial carcinoids, may in fact represent a group of tumors with different histogenesis and/or differentiative pattern. More work should be done to elucidate whether there is any relevant clinical difference between bronchial carcinoids with or without S-100 reactive cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852863     DOI: 10.1177/030089168807400615

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

1.  Bronchial carcinoid with paranuclear fibrillary inclusions related to cytokeratins and vimentin.

Authors:  M Barbareschi; B Frigo; S Cristina; L Valentini; E Leonardi; L Mosca
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 2.  Duodenal gangliocytic paraganglioma. Report of a case and review of the literature.

Authors:  M Barbareschi; B Frigo; D Aldovini; E Leonardi; S Cristina; M Falleni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  [S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation].

Authors:  A Warth; S Krysa; T Zahel; H Hoffmann; P Schirmacher; P A Schnabel; E Herpel
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.